Diabetes and chronic inflammation for future research development by Bando, Hiroshi
 Manuscript no: DROA-1-e101 Volume: 1      Issue: 1   1 
Diab Res 
 Editorial 
Diabetes Research: Open Access 
Diabetes and chronic inflammation for future research development 
Hiroshi Bando
1,2 
1Tokushima University / Medical Research, Tokushima, Japan 
2Japan Low Carbohydrate Diet Promotion Association, Kyoto, Japan 
Corresponding Author: Hiroshi Bando, MD, PhD, FACP 
Address: Tokushima University /Medical Research, Nakashowa 1-61, Tokushima-770-0943, Japan; E-mail: 
pianomed@bronze.ocn.ne.jp
Received date: 15 August 2019; Accepted date: 17 August 2019; Published date: 26 August 2019 
Citation: Bando H. Diabetes and chronic inflammation for future research development. Diab Res. 2019 Aug 
26;1(1):1-4. 
Copyright © 2019 Hiroshi Bando. This is an open-access article distributed under the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited. 
Keywords 
    Diabetes Research: Open Access (DROA); Non-Communicable Diseases (NCDs); Lifestyle-Related Diseases; 
Damage-Associated Molecular Patterns (DMAPs); Chronic Inflammation; Adipose Tissue 
 
 
 
 
Editorial 
    Congratulations on the inaugural issue of Diabetes 
Research: Open Access (DROA). Across the world, the 
necessity of medical practice and research concerning 
diabetes has been more emphasized. The significant 
role of this journal will be expected from now. 
    In recent years, lifestyle-related diseases such as 
obesity and diabetes have increased worldwide as 
non-communicable diseases (NCDs). Statistically, 71% 
of 57 million world deaths in 2016 were from NCDs 
[1]. The United Nations meeting on NCSs reviewed 
the global progress for the prevention and control of 
NCDs, and proposed countdown 2030 for reduction of 
the burden of NCDs [1]. Among NCDs, diabetes and 
hypertension have been prevalent and important to 
manage in the clinical practice [2]. 
    On the other hand, various problems concerning 
cancer have been also important. It is said that the 
prevalence of cancer is generally higher in patients 
with obesity and diabetes mellitus [3]. The burden of 
cancer attributable to obesity, expressed as population 
attributable fraction is 11.9%/13.1% in men/women. 
[3].  
    As mentioned above, the mechanisms of chronic 
inflammation are common in both lifestyle-related 
diseases and cancer. Metabolic syndrome would be 
one of the major onsets of lifestyle-related diseases 
such as cardiovascular disease, diabetes, and 
dyslipidemia. The crucial point is the inflammation. In 
the visceral adipose tissue associated with obesity, 
chronic inflammation is present on the basis. 
Furthermore, it seems to be involved in the 
pathophysiology of lifestyle-related diseases and to 
promote the developing throughout the body [4]. In 
other words, each lifestyle habit such as overeating or 
lack of exercise can cause obesity and chronic 
inflammation in adipose tissue. 
    On the other hand, another important factor would 
be the aging mechanism along the natural course of 
the human. With the process of aging, there is a 
similar finding to the chronic inflammation observed 
in the adipose tissue. There are macrophages and 
lymphocytes, which are immune cells that infiltrate 
the adipose tissue. They have changed their traits to 
promote the inflammatory process, leading to the 
pathogenesis of lifestyle-related disease [4]. As 
described above, the pathology involves two 
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mechanisms, which are chronic inflammation and 
aging. 
 
    Metabolism and the immune system always 
interact with each other. The presence of immune 
response will bring the onset of the inflammation, 
which affects the control of metabolism. Conversely, 
metabolic changes alter the inflammatory response. 
This close mutual influence can maintain various 
homeostasis of the human body. This failure may lead 
to the development of lifestyle-related diseases and 
the onset of cancer.  
 
    From the histological point of view, obesity shows 
the presence of the inflammatory response in the 
adipose tissue. Specifically, monocyte-derived pro-
inflammatory macrophages (M1) and CD8 + T cell 
infiltration increase in adipose tissue [5]. As a result, 
the ratios of inflammation converging macrophages 
(M2), CD4 + T cells, and eosinophils are relatively 
decreased. This mechanism has been involved in the 
immune function of various organs [6]. In obesity, 
muscle inflammation also occurs as a result of 
immune cell infiltration and activation [7]. Then, 
subsequent myocyte metabolic alteration may lead to 
insulin resistance development [7]. 
 
    When inflammation occurs in adipose tissue, its 
function will be affected. For example, various 
inflammatory cytokines, TNF-α, can inhibit insulin 
signaling, promote lipolysis, and increase the amount 
of free fatty acids [8]. Recently, Palmitoleic acid has 
been in focus for increasing fatty acid oxidation in 
white adipocytes [9]. High levels of free fatty acids are 
known to correlate with the onset of heart death and 
type-2 diabetes, and diets rich in saturated fatty acids 
(SFA) are also associated with the onset of type 2 
diabetes and coronary artery disease [10]. SFA 
induced insulin resistance, endotoxemia and 
significantly increased harmful plasma ceramides. 
Furthermore, SAT increases lipolysis, while 
unsaturated fatty acids decrease lipolysis [11]. 
 
    The pathophysiological process leading to diabetes 
has been known. As the inflammation occurs in 
adipose tissue, the metabolism for lipolysis would be 
enhanced [12]. Then, increased free fatty acid (FFA) 
in the blood can cause inflammatory changes in the 
pancreas [13]. Furthermore, pro-inflammatory 
macrophages infiltrate in the islets, leading to 
impaired cell function. As a result, insulin secretion 
will be gradually reduced, and diabetic status will be 
merged.   
 
    From the viewpoint of basic medicine, the 
Inflammation has been a typical biodefense response 
to various internal and external stresses. Essentially, 
it is a protective and adaptive response for the body. It 
has been classified into some situations due to 
different causes. 
 
    The first is acute inflammation. This is induced by 
microbial infection or some wounds. The 
characteristics are four typical biodefense reactions. 
They are fever, redness, pain, and swelling, which 
have been well-known as four factors for the presence 
of the inflammation. These often converge transiently 
and return back to the previous healthy state when 
the peak of the inflammatory response has been 
subsided. 
 
    Second is chronic inflammation, which is observed 
in lifestyle-related diseases and metabolic syndrome 
[14]. The characteristic is that it does not show four 
characteristics of inflammation. On the other hand, 
low level of inflammatory condition has been 
persisting for long. Actually, there are persisting 
higher C-reactive protein (CRP) levels in patients with 
obesity and lifestyle diseases and also in animal 
models. It is known that mild inflammation persists 
throughout the body. These mild inflammatory 
responses can lead to tissue function modulation, 
organ damage, and irreversible organ dysfunction due 
to tissue remodeling. 
 
    Regarding lifestyle-related diseases, a lot of factors 
related to persisting inflammation have been 
considered to be non-infectious (aseptic 
inflammation). For example, enteric bacteria 
withdrawal products also contribute to the initiation 
and persistence of these natural inflammations [15]. 
Furthermore, it is recently proposed that 
mitochondrial damage-associated molecular patterns 
(DMAPs) are involved in chronic inflammatory 
 Manuscript no: DROA-1-e101 Volume: 1      Issue: 1    3 
Diab Res 
 
 Editorial 
Citation: Bando H. Diabetes and chronic inflammation for future research development. Diab Res. 2019 Aug 
26;1(1):1-4. 
 
situations [16]. 
 
    For the pathogenesis of chronic inflammatory 
disorders, mitochondria shows crucial role. When the 
mitochondrial physiology has been perturbed, 
dysfunctional mitochondria may instigate or 
propagate inappropriate and persistent inflammation. 
Its mechanism is proceeded by some factors, including 
inflammasomes activation, dysregulation of immune 
signaling, alteration of immunometabolism and the 
release of mitochondrial DAMPs. Consequently, it 
leads to some chronic inflammatory disorders in 
affected organs or systematically. 
 
    In summary, this article revealed the relationship 
between chronic inflammation, adipose tissue and 
lifestyle-related diseases such as obesity and diabetes. 
I hope the description would become a useful 
reference in diabetic research from now. 
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